Bormioli Pharma to repay revolver and bilateral facilities with notes

By Sara Rosenberg

New York, April 24 – Bormioli Pharma SpA plans to repay all outstanding debt under its revolving credit facility and bilateral facilities using a portion of the proceeds from a €350 million senior secured notes offering, according to a market source.

Remaining proceeds from the notes will be used to repay €280 million of floating-rate notes due November 2024 and to pay transaction related fees and expenses.

Bormioli Pharma is a plastic and glass packaging provider for the pharmaceutical end market.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.